NIH Guide: Weekly Index for March 15, 2024

Funding Opportunities

• NIDCR Mentoring Network to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trial Not Allowed)
  (PAR-24-104)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
  (PAR-24-121)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• NINDS Advanced Institutional Research Training Program (T32 Clinical Trial Not Allowed)
  (PAR-24-126)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
  (PAR-24-144)
  National Institute of General Medical Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
  (PAR-24-145)
  National Institute of General Medical Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed)
  (PAR-24-167)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
• Exploring Proteogenomic Approaches to Unravel the Mechanisms of Mis-Folded Protein Accumulation in Tauopathies (R01 Clinical Trial Not Allowed)
  (RFA-AG-25-017)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed)
  (RFA-AI-23-077)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Trial Not Allowed)
  (RFA-DA-25-004)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Trial Not Allowed)
  (RFA-DA-25-005)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical Trial Not Allowed
  (RFA-FD-24-035)
  Food and Drug Administration
  Application Receipt Date(s): May 20, 2024
• Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
  (RFA-OD-24-014)
  Office of Dietary Supplements
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.